$1.38 -0.05 (%) Delcath Systems Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 25, 2014 | 11:01AM EST
  2. US Stock Futures Edge Higher; Crude Oil Rises

    Benzinga | Nov. 10, 2014 | 07:18AM EST
  3. Delcath Announces Treatment Of First Patient In Phase 2 Trial Of Melphalan Hepatic Delivery System In Primary Liver Cancer

    Benzinga | Nov. 10, 2014 | 06:33AM EST
  4. Earnings Scheduled For March 12, 2014

    Benzinga | Mar. 12, 2014 | 05:09AM EST
  5. Delcath Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

    Benzinga | Dec. 13, 2013 | 06:34AM EST
  6. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 5, 2013 | 10:28AM EST
  7. US Stock Futures Up Ahead Of Fed Speakers

    Benzinga | Oct. 4, 2013 | 07:24AM EST
  8. Delcath Systems Eliminates 33% of Workforce

    Benzinga | Oct. 4, 2013 | 06:33AM EST
  9. Delcath Board Implements Leadership Transition Plan

    Benzinga | Sep. 13, 2013 | 06:16AM EST
  10. Delcath Receives CRL from FDA for Melbleztm Kit NDA

    Benzinga | Sep. 13, 2013 | 06:15AM EST
  11. Benzinga's Small Cap Movers for Monday February 4, 2013

    Benzinga | Feb. 4, 2013 | 10:34AM EST
  12. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 13, 2012 | 03:19AM EST
  13. Morning Market Losers

    Benzinga | Oct. 15, 2012 | 03:50AM EST
  14. Delcath Says FDA Designated NDA for Standard Review; Expects to Get 74 Day Letter by the End of October

    Benzinga | Oct. 15, 2012 | 02:59AM EST
  15. Delcath Says FDA Designated NDA for Standard Review; Expects to Get 74 Day Letter by the End of October

    Benzinga | Oct. 15, 2012 | 02:59AM EST
  16. Delcath Says FDA Designated NDA for Standard Review; Expects to Get 74 Day Letter by the End of October

    Benzinga | Oct. 15, 2012 | 02:58AM EST
  17. Benzinga's Microcap Movers for Monday October 8, 2012

    Benzinga | Oct. 8, 2012 | 12:35PM EST
  18. Delcath To Present At Upcoming Investor Conferences

    Benzinga | Aug. 8, 2012 | 00:37AM EST
  19. Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO

    GuruFocus | Jun. 11, 2012 | 07:10AM EST
  20. Post-Hoc Analysis Of Delcath's Phase 3 Trial Presented At ASCO

    Benzinga | Jun. 5, 2012 | 08:44AM EST
  21. UPDATE: Canaccord Genuity Decreases PT on Delcath Systems to $5

    Benzinga | Jun. 4, 2012 | 02:24AM EST
  22. Mid-Day Market Losers

    Benzinga | May. 25, 2012 | 07:08AM EST
  23. Mid-Day Market Losers

    Benzinga | May. 25, 2012 | 06:17AM EST
  24. Delcath Prices $20 Million Public Offering of Common Stock and Warrants

    Benzinga | May. 25, 2012 | 02:52AM EST
  25. Delcath Announces Proposed Public Offering Of Common Stock And Warrants

    Benzinga | May. 24, 2012 | 10:28AM EST
  26. Financial Breakfast: Morning News Summary for February 27, 2012

    Benzinga | Feb. 27, 2012 | 00:24AM EST
  27. Delcath Announces First CHEMOSAT Procedures in Germany

    Benzinga | Feb. 26, 2012 | 23:48PM EST
  28. Stocks To Watch For January 3

    Benzinga | Jan. 2, 2012 | 21:08PM EST
  29. Morning Market Losers

    Benzinga | Dec. 30, 2011 | 03:24AM EST
  30. A Peek Into The Market Before The Trading Starts

    Benzinga | Dec. 27, 2011 | 00:48AM EST
  31. Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany

    Benzinga | Dec. 26, 2011 | 23:45PM EST
  32. Microcap Movers for Wednesday December 21, 2011

    Benzinga | Dec. 21, 2011 | 11:33AM EST
  33. Delcath Systems Devastated by 'Inconclusive' Trial Data

    SchaeffersResearch | Sep. 1, 2011 | 10:26AM EST
Trading Center